Skip to main content
SpringerLink
Log in

Use of Quetiapine to Manage Patients Who Experienced Adverse Effects with Clozapine

  • Short Communication
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Goldstein JM. Atypical antipsychotic drugs: beyond acute psychosis, new directions. Emerg Drugs 1999; 4: 137–51

    Google Scholar 

  2. Wirshing DA, Wirshing WC, Marder SR, Saunders CS, Rossotto EH, Erhadt SM. Atypical antipsychotics: a practical review [online]. Available from URL: http://psychiatry.medscape.com/Home/Topics/psychiatry/psychiatry.html. [Accessed 2000 Feb 18]

  3. Markowitz JS, Brown CS, Moore TR. Atypical antipsychotics: Part I. pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 1999; 33: 73–85

    Article  CAS  PubMed  Google Scholar 

  4. Stahl SM. Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials. J Clin Psychiatry 1999; 60: 31–41

    PubMed  Google Scholar 

  5. Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993; 329: 162–7

    Article  CAS  PubMed  Google Scholar 

  6. Goren JL, Levin GM. Quetiapine, an atypical antipsychotic. Pharmacotherapy 1998; 18: 1183–94

    CAS  PubMed  Google Scholar 

  7. Worrel JA, Marken PA, Beckman SE, et al. Atypical antipsychotic agents: a critical review. Am J Health Syst Pharm 2000; 57: 238–55

    CAS  PubMed  Google Scholar 

  8. Reinstein MJ, Sirotovskaya LA, Chasanov MA, et al. Comparative efficacy and tolerability of benzatropine and terazosin in the treatment of hypersalivation secondary to clozapine. Clin Drug Invest 1999; 17(2): 97–102

    Article  CAS  Google Scholar 

  9. Kalali A. Patient satisfaction with, and acceptability of, atypical antipsychotics [letter]. Curr Med Res Opin 1999; 15: 135–7

    Article  CAS  PubMed  Google Scholar 

  10. Fabre Jr LF, Arvanitis L, Pultz J, et al. ICI 204, 636, a novel, atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia. Clin Ther 1995; 17: 366–78

    Article  PubMed  Google Scholar 

  11. Borison RL, Arvanitis LA, Miller BG. ICI 204, 636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. US SEROQUEL Study Group. J Clin Psychopharmacol 1996; 16: 158–69

    Article  CAS  PubMed  Google Scholar 

  12. Peuskens J, Link CG. A comparison of quetiapine and chlorpromazine in the treatment of schizophrenia. Acta Psychiatr Scand 1997; 96: 265–73

    Article  CAS  PubMed  Google Scholar 

  13. Small JG, Hirsch SR, Arvanitis LA, et al. Quetiapine in patients with schizophrenia: a high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 1997; 54: 549–57

    Article  CAS  PubMed  Google Scholar 

  14. Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204, 636, ’seroquel’) and haloperidol in schizophrenia. Psychol Med 2000; 30: 95–105

    Article  CAS  PubMed  Google Scholar 

  15. Emsley RA, Raniwalla J, Bailey PJ, et al. A comparison of the effects of quetiapine and haloperidol in schizophrenic patients with a history of and a demonstrated, partial response to conventional antipsychotic treatment: PRIZE Study Group. Int Clin Psychopharmacol 2000; 15: 121–31

    Article  CAS  PubMed  Google Scholar 

  16. Ganguli R. Weight gain associated with antipsychotic drugs. J Clin Psychiatry 1999; 60: 20–4

    PubMed  Google Scholar 

  17. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686–96

    CAS  PubMed  Google Scholar 

  18. Brecher M, Rak IW, Melvin K, et al. The long-term effect of quetiapine monotherapy on weight in patients with schizophrenia. Int J Psych Clin Pract 2000; 4: 287–91

    Article  CAS  Google Scholar 

  19. McConville BJ, Arvanitis LA, Thyrum PT, et al. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 2000; 61: 252–60

    Article  CAS  PubMed  Google Scholar 

  20. McManus DQ, Arvanitis LA, Kowalcyk BB. Quetiapine, a novel antipsychotic: experience in elderly patients with psychotic disorders. Seroquel Trial 48 Study Group. J Clin Psychiatry 1999; 60: 292–8

    Article  CAS  PubMed  Google Scholar 

  21. Tariot PN, Salzman, C, et al. Long-term use of quetiapine in elderly patients with psychotic disorders. Clin Ther 2000; 22: 1068–84

    Article  CAS  PubMed  Google Scholar 

  22. Cantillio M, Goldstein J. Quetiapine fumarate reduces aggression and hostility in patients with schizophrenia [oral presentation]. 151st Annual Meeting of the American Psychiatric Association; 1998 Jun 3, Toronto (Ontario), Canada

  23. Goldstein J. Quetiapine fumarate: effects of hostility, aggression and affective symptoms in patients with acute schizophrenia [oral presentation]. 38th Annual Meeting of the New Clinical Drug Evaluation Unit; 1998 Jun 10–15; Boca Raton (FL), USA

Download references

Acknowledgements

This research was supported in part by an unrestricted educational grant from Novartis Pharmaceuticals Corporation.

Author information

Authors and Affiliations

  1. Uptown Research Institute, 4755 North Kenmore Street, Chicago, Illinois, 60640, USA

    Michael J. Reinstein, John G. Sonnenberg, Sangarapillai C. Mohan, Maxim A. Chasanov & Lynne E. Jones

Authors
  1. Michael J. Reinstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John G. Sonnenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sangarapillai C. Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maxim A. Chasanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lynne E. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John G. Sonnenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Reinstein, M.J., Sonnenberg, J.G., Mohan, S.C. et al. Use of Quetiapine to Manage Patients Who Experienced Adverse Effects with Clozapine. Clin Drug Investig 23, 63–67 (2003). https://doi.org/10.2165/00044011-200323010-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200323010-00008

Keywords

Search

Navigation